Using data from the prospective Netherlands Cohort Study (NLCS), we investigated whether mutational subtypes based on mutations known to promote the Warburg‐effect (RAS, BRAF, PIK3CA, MET), as well as mismatch repair (MMR) status, are associated with CRC survival. The gene discussed is MET; the disease is colorectal carcinoma.